Structure

Physi-Chem Properties

Molecular Weight:  192.08
Volume:  197.524
LogP:  2.265
LogD:  2.587
LogS:  -2.927
# Rotatable Bonds:  2
TPSA:  27.69
# H-Bond Aceptor:  3
# H-Bond Donor:  0
# Rings:  2
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.72
Synthetic Accessibility Score:  2.333
Fsp3:  0.273
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.599
MDCK Permeability:  1.7269278032472357e-05
Pgp-inhibitor:  0.362
Pgp-substrate:  0.932
Human Intestinal Absorption (HIA):  0.002
20% Bioavailability (F20%):  0.001
30% Bioavailability (F30%):  0.007

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.486
Plasma Protein Binding (PPB):  94.24723815917969%
Volume Distribution (VD):  1.911
Pgp-substrate:  3.6459543704986572%

ADMET: Metabolism

CYP1A2-inhibitor:  0.995
CYP1A2-substrate:  0.88
CYP2C19-inhibitor:  0.862
CYP2C19-substrate:  0.817
CYP2C9-inhibitor:  0.184
CYP2C9-substrate:  0.907
CYP2D6-inhibitor:  0.913
CYP2D6-substrate:  0.91
CYP3A4-inhibitor:  0.81
CYP3A4-substrate:  0.37

ADMET: Excretion

Clearance (CL):  12.117
Half-life (T1/2):  0.605

ADMET: Toxicity

hERG Blockers:  0.033
Human Hepatotoxicity (H-HT):  0.068
Drug-inuced Liver Injury (DILI):  0.466
AMES Toxicity:  0.022
Rat Oral Acute Toxicity:  0.014
Maximum Recommended Daily Dose:  0.154
Skin Sensitization:  0.821
Carcinogencity:  0.898
Eye Corrosion:  0.727
Eye Irritation:  0.945
Respiratory Toxicity:  0.442

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC33271

Natural Product ID:  NPC33271
Common Name*:   Isomyristicin
IUPAC Name:   4-methoxy-6-[(E)-prop-1-enyl]-1,3-benzodioxole
Synonyms:   Isomyristicin
Standard InCHIKey:  DHUZAAUGHUHIDS-ONEGZZNKSA-N
Standard InCHI:  InChI=1S/C11H12O3/c1-3-4-8-5-9(12-2)11-10(6-8)13-7-14-11/h3-6H,7H2,1-2H3/b4-3+
SMILES:  C/C=C/c1cc(c2c(c1)OCO2)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1642213
PubChem CID:   6436484
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000296] Benzodioxoles

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18951 Ligusticum sinense Species Apiaceae Eukaryota n.a. n.a. n.a. PMID[26521454]
NPO9662 Conioselinum vaginatum Species Apiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO4176 Mosla scabra Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO18951 Ligusticum sinense Species Apiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO4176 Mosla scabra Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO9662 Conioselinum vaginatum Species Apiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO18951 Ligusticum sinense Species Apiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO18951 Ligusticum sinense Species Apiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO9662 Conioselinum vaginatum Species Apiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO18951 Ligusticum sinense Species Apiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO18951 Ligusticum sinense Species Apiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO4176 Mosla scabra Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2588 Organism Paracentrotus lividus Paracentrotus lividus EC > 5.0 uM PMID[568993]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC33271 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.982 High Similarity NPC119949
0.9316 High Similarity NPC191768
0.9316 High Similarity NPC92869
0.9316 High Similarity NPC283170
0.931 High Similarity NPC211231
0.9273 High Similarity NPC203924
0.9266 High Similarity NPC165386
0.9266 High Similarity NPC127326
0.9107 High Similarity NPC204120
0.9009 High Similarity NPC31279
0.9 High Similarity NPC473960
0.8934 High Similarity NPC228769
0.8934 High Similarity NPC470633
0.887 High Similarity NPC123948
0.8862 High Similarity NPC63574
0.8793 High Similarity NPC52464
0.8793 High Similarity NPC259638
0.8793 High Similarity NPC304208
0.879 High Similarity NPC192255
0.8729 High Similarity NPC222175
0.8707 High Similarity NPC193067
0.8651 High Similarity NPC136750
0.8651 High Similarity NPC266848
0.8651 High Similarity NPC471391
0.8651 High Similarity NPC196937
0.8651 High Similarity NPC58585
0.8651 High Similarity NPC471390
0.8644 High Similarity NPC308217
0.8644 High Similarity NPC15805
0.8644 High Similarity NPC20674
0.8644 High Similarity NPC475961
0.8644 High Similarity NPC254625
0.8632 High Similarity NPC212643
0.8632 High Similarity NPC199209
0.8624 High Similarity NPC310905
0.8624 High Similarity NPC12714
0.8583 High Similarity NPC310373
0.8571 High Similarity NPC72046
0.8571 High Similarity NPC229401
0.8571 High Similarity NPC65183
0.8571 High Similarity NPC261812
0.856 High Similarity NPC184814
0.8559 High Similarity NPC63083
0.8547 High Similarity NPC111225
0.8516 High Similarity NPC189474
0.8512 High Similarity NPC288238
0.85 High Similarity NPC472596
0.85 High Similarity NPC199023
0.85 High Similarity NPC166759
0.8492 Intermediate Similarity NPC473412
0.8492 Intermediate Similarity NPC469698
0.8487 Intermediate Similarity NPC69670
0.8468 Intermediate Similarity NPC292792
0.845 Intermediate Similarity NPC143895
0.845 Intermediate Similarity NPC172818
0.845 Intermediate Similarity NPC25695
0.8438 Intermediate Similarity NPC256776
0.8438 Intermediate Similarity NPC31530
0.8438 Intermediate Similarity NPC145722
0.8438 Intermediate Similarity NPC185680
0.843 Intermediate Similarity NPC285289
0.843 Intermediate Similarity NPC193484
0.843 Intermediate Similarity NPC477886
0.8425 Intermediate Similarity NPC162093
0.8421 Intermediate Similarity NPC82016
0.8417 Intermediate Similarity NPC61516
0.8417 Intermediate Similarity NPC344161
0.8417 Intermediate Similarity NPC474565
0.8417 Intermediate Similarity NPC247364
0.8417 Intermediate Similarity NPC232084
0.8417 Intermediate Similarity NPC10932
0.8403 Intermediate Similarity NPC474612
0.8387 Intermediate Similarity NPC285725
0.8387 Intermediate Similarity NPC112571
0.8387 Intermediate Similarity NPC50683
0.8387 Intermediate Similarity NPC52593
0.8385 Intermediate Similarity NPC196420
0.8385 Intermediate Similarity NPC195196
0.8385 Intermediate Similarity NPC185908
0.8385 Intermediate Similarity NPC20796
0.8372 Intermediate Similarity NPC148893
0.8372 Intermediate Similarity NPC38101
0.8372 Intermediate Similarity NPC25333
0.8372 Intermediate Similarity NPC73071
0.8372 Intermediate Similarity NPC150534
0.8372 Intermediate Similarity NPC49235
0.8372 Intermediate Similarity NPC240915
0.8361 Intermediate Similarity NPC194626
0.8361 Intermediate Similarity NPC262253
0.8361 Intermediate Similarity NPC261661
0.8361 Intermediate Similarity NPC473411
0.8361 Intermediate Similarity NPC71579
0.8361 Intermediate Similarity NPC270326
0.8359 Intermediate Similarity NPC49074
0.8359 Intermediate Similarity NPC112237
0.8359 Intermediate Similarity NPC1474
0.8359 Intermediate Similarity NPC132895
0.8333 Intermediate Similarity NPC226629
0.8333 Intermediate Similarity NPC57501
0.8308 Intermediate Similarity NPC11453
0.8308 Intermediate Similarity NPC121651
0.8308 Intermediate Similarity NPC197166
0.8308 Intermediate Similarity NPC32189
0.8306 Intermediate Similarity NPC58279
0.8306 Intermediate Similarity NPC300326
0.8306 Intermediate Similarity NPC27352
0.8295 Intermediate Similarity NPC7163
0.8293 Intermediate Similarity NPC282496
0.8293 Intermediate Similarity NPC108545
0.8293 Intermediate Similarity NPC233526
0.8293 Intermediate Similarity NPC238810
0.8281 Intermediate Similarity NPC299144
0.8281 Intermediate Similarity NPC470270
0.8281 Intermediate Similarity NPC7744
0.8279 Intermediate Similarity NPC301641
0.8279 Intermediate Similarity NPC80241
0.8279 Intermediate Similarity NPC49341
0.8279 Intermediate Similarity NPC114845
0.8258 Intermediate Similarity NPC284464
0.8254 Intermediate Similarity NPC222127
0.8254 Intermediate Similarity NPC226862
0.8254 Intermediate Similarity NPC165128
0.8254 Intermediate Similarity NPC82862
0.8254 Intermediate Similarity NPC57119
0.8254 Intermediate Similarity NPC158471
0.8246 Intermediate Similarity NPC227894
0.8246 Intermediate Similarity NPC258171
0.8246 Intermediate Similarity NPC35543
0.8244 Intermediate Similarity NPC283949
0.8244 Intermediate Similarity NPC474039
0.824 Intermediate Similarity NPC127604
0.824 Intermediate Similarity NPC88297
0.824 Intermediate Similarity NPC9891
0.824 Intermediate Similarity NPC186845
0.8231 Intermediate Similarity NPC470236
0.8231 Intermediate Similarity NPC236522
0.8226 Intermediate Similarity NPC183446
0.8226 Intermediate Similarity NPC5796
0.8226 Intermediate Similarity NPC206487
0.8217 Intermediate Similarity NPC215833
0.8217 Intermediate Similarity NPC69513
0.8211 Intermediate Similarity NPC264885
0.8211 Intermediate Similarity NPC256167
0.8211 Intermediate Similarity NPC41562
0.8205 Intermediate Similarity NPC280606
0.8203 Intermediate Similarity NPC227160
0.8203 Intermediate Similarity NPC82111
0.8195 Intermediate Similarity NPC312199
0.8195 Intermediate Similarity NPC58137
0.8195 Intermediate Similarity NPC300798
0.8182 Intermediate Similarity NPC30951
0.8182 Intermediate Similarity NPC6369
0.8182 Intermediate Similarity NPC113550
0.8182 Intermediate Similarity NPC53722
0.8182 Intermediate Similarity NPC290714
0.8182 Intermediate Similarity NPC9068
0.8182 Intermediate Similarity NPC292487
0.8182 Intermediate Similarity NPC201404
0.8175 Intermediate Similarity NPC473093
0.8175 Intermediate Similarity NPC473092
0.8175 Intermediate Similarity NPC194841
0.8175 Intermediate Similarity NPC8050
0.8174 Intermediate Similarity NPC245115
0.8168 Intermediate Similarity NPC164857
0.816 Intermediate Similarity NPC475169
0.816 Intermediate Similarity NPC265483
0.816 Intermediate Similarity NPC299584
0.816 Intermediate Similarity NPC82483
0.816 Intermediate Similarity NPC203133
0.816 Intermediate Similarity NPC251855
0.816 Intermediate Similarity NPC472093
0.816 Intermediate Similarity NPC233410
0.816 Intermediate Similarity NPC234400
0.816 Intermediate Similarity NPC105925
0.816 Intermediate Similarity NPC208950
0.816 Intermediate Similarity NPC193544
0.816 Intermediate Similarity NPC298757
0.816 Intermediate Similarity NPC60885
0.816 Intermediate Similarity NPC116907
0.816 Intermediate Similarity NPC117214
0.816 Intermediate Similarity NPC173608
0.816 Intermediate Similarity NPC221077
0.816 Intermediate Similarity NPC57490
0.816 Intermediate Similarity NPC271985
0.816 Intermediate Similarity NPC17943
0.816 Intermediate Similarity NPC85830
0.8158 Intermediate Similarity NPC164576
0.8154 Intermediate Similarity NPC107478
0.8154 Intermediate Similarity NPC13745
0.8154 Intermediate Similarity NPC251981
0.8154 Intermediate Similarity NPC48863
0.8145 Intermediate Similarity NPC165375
0.8145 Intermediate Similarity NPC228922
0.8145 Intermediate Similarity NPC197757
0.8145 Intermediate Similarity NPC249788
0.8145 Intermediate Similarity NPC220598
0.814 Intermediate Similarity NPC252833
0.8134 Intermediate Similarity NPC210354
0.8134 Intermediate Similarity NPC176586
0.8134 Intermediate Similarity NPC80326

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC33271 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8583 High Similarity NPD3705 Approved
0.8487 Intermediate Similarity NPD1357 Approved
0.8361 Intermediate Similarity NPD2981 Phase 2
0.8293 Intermediate Similarity NPD2982 Phase 2
0.8293 Intermediate Similarity NPD2983 Phase 2
0.8031 Intermediate Similarity NPD3018 Phase 2
0.7966 Intermediate Similarity NPD228 Approved
0.7907 Intermediate Similarity NPD3027 Phase 3
0.7833 Intermediate Similarity NPD5283 Phase 1
0.7786 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7652 Intermediate Similarity NPD554 Clinical (unspecified phase)
0.7581 Intermediate Similarity NPD5536 Phase 2
0.7557 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7481 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7463 Intermediate Similarity NPD1613 Approved
0.7463 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7445 Intermediate Similarity NPD3539 Phase 1
0.7426 Intermediate Similarity NPD6111 Discontinued
0.7397 Intermediate Similarity NPD37 Approved
0.7391 Intermediate Similarity NPD3540 Phase 1
0.7361 Intermediate Similarity NPD1653 Approved
0.7353 Intermediate Similarity NPD2492 Phase 1
0.7333 Intermediate Similarity NPD1358 Approved
0.7324 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7324 Intermediate Similarity NPD5297 Approved
0.7287 Intermediate Similarity NPD1091 Approved
0.7266 Intermediate Similarity NPD1375 Discontinued
0.7265 Intermediate Similarity NPD1242 Phase 1
0.7248 Intermediate Similarity NPD4966 Approved
0.7248 Intermediate Similarity NPD4965 Approved
0.7248 Intermediate Similarity NPD4967 Phase 2
0.7244 Intermediate Similarity NPD1548 Phase 1
0.7203 Intermediate Similarity NPD4357 Discontinued
0.7183 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7171 Intermediate Similarity NPD7199 Phase 2
0.7154 Intermediate Similarity NPD1610 Phase 2
0.7154 Intermediate Similarity NPD422 Phase 1
0.7152 Intermediate Similarity NPD6234 Discontinued
0.7133 Intermediate Similarity NPD7124 Phase 2
0.7131 Intermediate Similarity NPD2684 Approved
0.7107 Intermediate Similarity NPD3134 Approved
0.7078 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD2219 Phase 1
0.7049 Intermediate Similarity NPD290 Approved
0.7034 Intermediate Similarity NPD1424 Approved
0.7031 Intermediate Similarity NPD1408 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD1726 Clinical (unspecified phase)
0.6986 Remote Similarity NPD1940 Clinical (unspecified phase)
0.6983 Remote Similarity NPD9296 Approved
0.6977 Remote Similarity NPD7534 Approved
0.6977 Remote Similarity NPD7533 Approved
0.6963 Remote Similarity NPD9494 Approved
0.6959 Remote Similarity NPD6055 Clinical (unspecified phase)
0.6957 Remote Similarity NPD1558 Phase 1
0.6944 Remote Similarity NPD5084 Clinical (unspecified phase)
0.6935 Remote Similarity NPD556 Approved
0.6923 Remote Similarity NPD4237 Approved
0.6923 Remote Similarity NPD4236 Phase 3
0.6917 Remote Similarity NPD291 Approved
0.6917 Remote Similarity NPD846 Approved
0.6917 Remote Similarity NPD4749 Approved
0.6917 Remote Similarity NPD940 Approved
0.6912 Remote Similarity NPD4908 Phase 1
0.6912 Remote Similarity NPD5752 Clinical (unspecified phase)
0.6906 Remote Similarity NPD230 Phase 1
0.6905 Remote Similarity NPD7843 Approved
0.6897 Remote Similarity NPD6783 Clinical (unspecified phase)
0.6894 Remote Similarity NPD776 Approved
0.6889 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7157 Approved
0.6875 Remote Similarity NPD709 Approved
0.6871 Remote Similarity NPD1350 Approved
0.6871 Remote Similarity NPD1349 Approved
0.6871 Remote Similarity NPD1351 Approved
0.6866 Remote Similarity NPD2922 Phase 1
0.6863 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6861 Remote Similarity NPD2669 Clinical (unspecified phase)
0.6857 Remote Similarity NPD1772 Clinical (unspecified phase)
0.6846 Remote Similarity NPD7261 Clinical (unspecified phase)
0.6846 Remote Similarity NPD1182 Approved
0.6835 Remote Similarity NPD7228 Approved
0.6835 Remote Similarity NPD3818 Discontinued
0.6825 Remote Similarity NPD1139 Approved
0.6825 Remote Similarity NPD1137 Approved
0.6821 Remote Similarity NPD3382 Approved
0.6821 Remote Similarity NPD3383 Approved
0.6821 Remote Similarity NPD3384 Approved
0.6818 Remote Similarity NPD919 Approved
0.6812 Remote Similarity NPD5718 Phase 2
0.6812 Remote Similarity NPD3144 Approved
0.6812 Remote Similarity NPD5110 Phase 2
0.6812 Remote Similarity NPD3145 Approved
0.6812 Remote Similarity NPD5109 Approved
0.6812 Remote Similarity NPD5111 Phase 2
0.6812 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6812 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6806 Remote Similarity NPD6674 Discontinued
0.68 Remote Similarity NPD4678 Approved
0.68 Remote Similarity NPD4675 Approved
0.68 Remote Similarity NPD5451 Approved
0.6797 Remote Similarity NPD3882 Suspended
0.6794 Remote Similarity NPD5691 Approved
0.6788 Remote Similarity NPD1008 Clinical (unspecified phase)
0.6786 Remote Similarity NPD1933 Approved
0.6783 Remote Similarity NPD7266 Discontinued
0.6776 Remote Similarity NPD2978 Approved
0.6776 Remote Similarity NPD2977 Approved
0.6772 Remote Similarity NPD1138 Approved
0.6763 Remote Similarity NPD2674 Phase 3
0.6742 Remote Similarity NPD4626 Approved
0.6742 Remote Similarity NPD1778 Approved
0.6742 Remote Similarity NPD17 Approved
0.6739 Remote Similarity NPD4625 Phase 3
0.6733 Remote Similarity NPD4005 Discontinued
0.6732 Remote Similarity NPD3817 Phase 2
0.6732 Remote Similarity NPD6374 Clinical (unspecified phase)
0.6714 Remote Similarity NPD3620 Phase 2
0.6714 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6713 Remote Similarity NPD3454 Phase 3
0.6711 Remote Similarity NPD1934 Approved
0.6691 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6689 Remote Similarity NPD7028 Phase 2
0.6687 Remote Similarity NPD7054 Approved
0.6667 Remote Similarity NPD4210 Discontinued
0.6667 Remote Similarity NPD2801 Approved
0.6667 Remote Similarity NPD447 Suspended
0.6667 Remote Similarity NPD5058 Phase 3
0.6667 Remote Similarity NPD7240 Approved
0.6667 Remote Similarity NPD1651 Approved
0.6667 Remote Similarity NPD5494 Approved
0.6667 Remote Similarity NPD3657 Discovery
0.6646 Remote Similarity NPD7074 Phase 3
0.6646 Remote Similarity NPD7472 Approved
0.6645 Remote Similarity NPD5089 Approved
0.6645 Remote Similarity NPD5090 Approved
0.6645 Remote Similarity NPD5604 Discontinued
0.6642 Remote Similarity NPD1281 Approved
0.6641 Remote Similarity NPD821 Approved
0.6641 Remote Similarity NPD5535 Approved
0.6624 Remote Similarity NPD1247 Approved
0.6623 Remote Similarity NPD5353 Approved
0.6622 Remote Similarity NPD1511 Approved
0.6621 Remote Similarity NPD1372 Clinical (unspecified phase)
0.6621 Remote Similarity NPD970 Clinical (unspecified phase)
0.662 Remote Similarity NPD2653 Approved
0.6597 Remote Similarity NPD2161 Phase 2
0.6596 Remote Similarity NPD1240 Approved
0.6594 Remote Similarity NPD2861 Phase 2
0.6593 Remote Similarity NPD1608 Approved
0.6593 Remote Similarity NPD1840 Phase 2
0.6589 Remote Similarity NPD1241 Discontinued
0.6581 Remote Similarity NPD9365 Approved
0.6581 Remote Similarity NPD6788 Approved
0.6577 Remote Similarity NPD4739 Approved
0.6577 Remote Similarity NPD3688 Clinical (unspecified phase)
0.6577 Remote Similarity NPD3146 Approved
0.6575 Remote Similarity NPD1652 Phase 2
0.6575 Remote Similarity NPD3060 Approved
0.6573 Remote Similarity NPD6896 Approved
0.6573 Remote Similarity NPD6895 Approved
0.6571 Remote Similarity NPD1296 Phase 2
0.6561 Remote Similarity NPD5677 Discontinued
0.656 Remote Similarity NPD968 Approved
0.6558 Remote Similarity NPD5563 Clinical (unspecified phase)
0.6558 Remote Similarity NPD4585 Approved
0.6545 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6544 Remote Similarity NPD5327 Phase 3
0.6541 Remote Similarity NPD3926 Phase 2
0.6541 Remote Similarity NPD5585 Approved
0.6538 Remote Similarity NPD4055 Discovery
0.6535 Remote Similarity NPD4750 Phase 3
0.6535 Remote Similarity NPD3021 Approved
0.6535 Remote Similarity NPD3022 Approved
0.6533 Remote Similarity NPD1512 Approved
0.6531 Remote Similarity NPD4110 Phase 3
0.6531 Remote Similarity NPD7466 Approved
0.6531 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6531 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6528 Remote Similarity NPD4108 Discontinued
0.6528 Remote Similarity NPD6028 Clinical (unspecified phase)
0.6528 Remote Similarity NPD6029 Clinical (unspecified phase)
0.6524 Remote Similarity NPD7808 Phase 3
0.6516 Remote Similarity NPD2358 Clinical (unspecified phase)
0.6503 Remote Similarity NPD1607 Approved
0.6503 Remote Similarity NPD6797 Phase 2
0.6496 Remote Similarity NPD1283 Approved
0.6496 Remote Similarity NPD8651 Approved
0.6491 Remote Similarity NPD111 Approved
0.6489 Remote Similarity NPD6671 Approved
0.6483 Remote Similarity NPD2796 Approved
0.648 Remote Similarity NPD9697 Approved
0.6478 Remote Similarity NPD6232 Discontinued
0.6467 Remote Similarity NPD4123 Phase 3
0.6466 Remote Similarity NPD9094 Approved
0.6463 Remote Similarity NPD7251 Discontinued
0.6463 Remote Similarity NPD1243 Approved
0.6452 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6447 Remote Similarity NPD3686 Approved
0.6447 Remote Similarity NPD3687 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data